Innovent Biologics, Inc. passed a special resolution on June 21, 2024 to complete the fifteenth revision and restatement of the company's articles of association. The revision involves many contents, such as the company name, registered office address, purpose of establishment, shareholder responsibilities, capital structure, cross-jurisdiction registration, and regulations of organizational articles. The revised regulations will change the company's capital and rights, and provide detailed specifications for the operation of the shareholders' meeting, shareholder voting, board of directors, management, and other aspects. This revision aims to enhance the corporate governance structure and provide a clearer legal framework for the future development of the company.

Innovent Biologics, Inc. passed a special resolution on June 21, 2024 to complete the fifteenth revision and restatement of the company's articles of association. The revision involves many contents, such as the company name, registered office address, purpose of establishment, shareholder responsibilities, capital structure, cross-jurisdiction registration, and regulations of organizational articles. The revised regulations will change the company's capital and rights, and provide detailed specifications for the operation of the shareholders' meeting, shareholder voting, board of directors, management, and other aspects. This revision aims to enhance the corporate governance structure and provide a clearer legal framework for the future development of the company.